Smith Nephew Other Liab Over Time
| SNN Stock | USD 25.31 0.27 1.08% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Smith Nephew Performance and Smith Nephew Correlation. Smith |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Smith Nephew listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.244 | Dividend Share 0.375 | Earnings Share 0.7 | Revenue Per Share 2.5904 | Quarterly Revenue Growth 0.034 |
The market value of Smith Nephew SNATS is measured differently than its book value, which is the value of Smith that is recorded on the company's balance sheet. Investors also form their own opinion of Smith Nephew's value that differs from its market value or its book value, called intrinsic value, which is Smith Nephew's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Smith Nephew's market value can be influenced by many factors that don't directly affect Smith Nephew's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Smith Nephew's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Liab Analysis
Compare Smith Nephew SNATS and related stocks such as CochLear ADR, Integer Holdings Corp, and ConforMIS Other Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ITGR | 790 K | 8.9 M | 9.4 M | 7.3 M | 4.5 M | 232.6 M | 223.3 M | 167.3 M | 213.6 M | 204.3 M | 213 M | 195.2 M | 172.8 M | 198.7 M | 102.1 M |
| OFIX | 3.4 M | 4 M | 4.9 M | 12.7 M | 26.9 M | 27.9 M | 25.2 M | 29.3 M | 45.3 M | 58.4 M | 39.8 M | 14 M | 13.5 M | 15.6 M | 16.4 M |
| GKOS | 737 K | 737 K | 737 K | 737 K | 391 K | 238 K | 159 K | 846 K | 2.7 M | 14.8 M | 17.5 M | 16.8 M | 17.5 M | 20.2 M | 21.2 M |
| BRKR | 4.5 M | 86.6 M | 116.9 M | 112.6 M | 138.4 M | 177.4 M | 199 M | 274.9 M | 279 M | 311 M | 389.4 M | 404.9 M | 318.2 M | 365.9 M | 384.2 M |
| GMED | 3.8 M | 11.9 M | 13.4 M | 19.6 M | 23.5 M | 36.1 M | 15.7 M | 17.7 M | 19 M | 17.1 M | 52.4 M | 75.7 M | 70.5 M | 81.1 M | 85.2 M |
| CNMD | 15.9 M | 49.6 M | 86.6 M | 45.3 M | 48.5 M | 127.4 M | 146.2 M | 104.8 M | 107.4 M | 104.2 M | 102.5 M | 98.8 M | 258.7 M | 297.5 M | 312.3 M |
| ATEC | 492 K | 13 M | 13.5 M | 38.8 M | 32.2 M | 33.8 M | 28.9 M | 20.2 M | 15.4 M | 12 M | 8.6 M | 367.9 M | 11.5 M | 13.3 M | 12.6 M |
| LIVN | 209 K | 5.4 M | 5.5 M | 5.2 M | 7.9 M | 294.6 M | 209.2 M | 219.9 M | 409.4 M | 209.1 M | 299 M | 163.7 M | 242.1 M | 278.5 M | 292.4 M |
| IRTC | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 124 K | 152 K | 161 K | 153 K | 1.8 M | 1.8 M | 697 K | 1.3 M | 1.2 M | 734.8 K |
| KIDS | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 63 K | 63 K | 63 K | 63 K | 63 K | 49.2 M | 48.3 M | 17.2 M | 19.8 M | 25.6 M |
| FNA | 918 K | 918 K | 918 K | 918 K | 918 K | 918 K | 918 K | 918 K | 918 K | 918 K | 918 K | 918 K | 1.1 M | 1.3 M | 1.1 M |
Smith Nephew SNATS and related stocks such as CochLear ADR, Integer Holdings Corp, and ConforMIS Other Liab description
My Equities
My Current Equities and Potential Positions
| Smith Nephew SNATS | SNN |
| Classification | Medical Equipment |
| Location | United Kingdom |
| Exchange | New York Stock Exchange |
USD 25.31
Check out Smith Nephew Performance and Smith Nephew Correlation. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Smith Nephew technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.